Market Overview:
The global irrigated ablation catheters market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of cancer, technological advancements in ablation devices, and rising demand for minimally invasive procedures. Based on type, the global irrigated ablation catheters market is segmented into radiofrequency (RF), cryoablation, laser, and others. The RF segment is expected to account for the largest share of the global market in 2018 owing to its high efficacy and safety profile. Based on application, the global irrigated ablation catheters market is segmented into hospitals, specialty clinics, ambulatory surgical centers (ASCs), diagnostic centers, and others. The hospitals segment accounted for the largest share of the global market in 2017 due to rising demand for minimally invasive procedures among patients.
Product Definition:
Irrigated Ablation Catheters are medical devices that are used to remove unwanted tissue from the body. They work by using a high-pressure stream of saline solution to clean the area around the tissue that is being removed. This helps to minimize bleeding and damage to surrounding tissues.
Radiofrequency (RF):
Radiofrequency (RF) is a form of electromagnetic radiation used in medical procedures. It’s an energy source that creates heat and helps destroy tissues by causing them to coagulate or cook. RF ablation catheters are used for the destruction of tissues and organs without affecting the surrounding areas, which makes it safer than surgical excision.
Cryoablation:
Cryoablation is a minimally invasive surgical procedure used to treat patients suffering from varicose veins, spider veins, and chronic venous insufficiency. The treatment involves the use of extremely cold temperatures to freeze and kill the affected tissues. It has been found to be effective in treating patients with refluxing or recurring leg ulcers as well as post-operative complications following angioplasty or coronary artery bypass graft surgery.
Application Insights:
Based on application, the global market is segmented into hospitals, specialty clinics, ambulatory surgical centers (ASCs), diagnostic centers and other facilities. The hospitals segment dominated the overall application segment in 2017 owing to a high prevalence of chronic diseases such as cancer and cardiovascular diseases that require regular medical checkups. In addition, increasing government initiatives to promote healthy lifestyle practices are expected to boost growth over the forecast period.
The ASCs are anticipated to be one of the fastest-growing segments during the forecast period due to an increase in demand for minimally invasive procedures due to factors such as growing geriatric population along with rising awareness about alternative treatment options across various regions of the world. Furthermore, increasing investments by companies operating in this sector will further boost product demand over next seven years.
Regional Analysis:
North America dominated the global irrigated ablation catheters market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of cancer and other diseases, presence of key players such as Boston Scientific Corporation; Medtronic; Stryker Corporation; and Intuitive Surgical, Inc., among others. Moreover, the region is expected to witness a CAGR of XX% during the forecast period due to technological advancements in devices used for ablation procedures along with an increase in government initiatives for cancer screening programs.
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period owing to factors such as economic development and improvement in healthcare infrastructure leading to an increase in awareness about various treatment options available for various diseases including prostate cancer. In addition, rising incidence rates of bladder & kidney cancers are also expected drive regional growth over the next eight years.
Growth Factors:
- Increasing incidence of cardiac arrhythmias: The global incidence of cardiac arrhythmias is increasing due to the aging population and rising prevalence of cardiovascular diseases. This is expected to drive the demand for irrigated ablation catheters as they are used for the treatment of cardiac arrhythmias.
- Technological advancements: The development of novel technologies such as contact force sensing and 3D mapping has helped in improving the accuracy and efficacy of irrigated ablation catheters, thereby driving their demand.
- Growing preference for minimally invasive procedures: There is a growing preference for minimally invasive procedures over traditional open surgery due to their lower risks and shorter recovery times. This is expected to boost the demand for irrigated ablation catheters as they are used in minimally invasive procedures.
- Rising healthcare expenditure: There has been a significant rise in healthcare expenditure across all regions in recent years, owing to factors such as rising income levels, aging populations, and increasing prevalence of chronic diseases. This is likely to spur growth in the market for irrigated ablation catheters over the forecast period.. 5) Increasing awareness about heart health: There has been an increase in awareness about heart health among consumers in recent years owing to campaigns by various organizations such as World Heart Federation (WHF). This is likely to leadto an increasein demandforirrigatedablationcathetersthatareusedforthetreatmentof
Scope Of The Report
Report Attributes
Report Details
Report Title
Irrigated Ablation Catheters Market Research Report
By Type
Radiofrequency (RF), Cryoablation, Laser, Others
By Application
Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others
By Companies
Boston Scientific Corporation, Osypka AG, Biosense Webster, Inc., Abbott, Medtronic, Biotronik, MicroPort Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Irrigated Ablation Catheters Market Report Segments:
The global Irrigated Ablation Catheters market is segmented on the basis of:
Types
Radiofrequency (RF), Cryoablation, Laser, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation
- Osypka AG
- Biosense Webster, Inc.
- Abbott
- Medtronic
- Biotronik
- MicroPort Scientific
Highlights of The Irrigated Ablation Catheters Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiofrequency (RF)
- Cryoablation
- Laser
- Others
- By Application:
- Hospitals
- Speciality Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Irrigated Ablation Catheters Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Irrigated ablation catheters are a type of medical device that use a controlled flow of water to cool and destroy tissue. They are used to treat certain types of cancer, such as prostate cancer.
Some of the major companies in the irrigated ablation catheters market are Boston Scientific Corporation, Osypka AG, Biosense Webster, Inc., Abbott, Medtronic, Biotronik, MicroPort Scientific.
The irrigated ablation catheters market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Irrigated Ablation Catheters Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Irrigated Ablation Catheters Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Irrigated Ablation Catheters Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Irrigated Ablation Catheters Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Irrigated Ablation Catheters Market Size & Forecast, 2020-2028
4.5.1 Irrigated Ablation Catheters Market Size and Y-o-Y Growth
4.5.2 Irrigated Ablation Catheters Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Radiofrequency (RF)
5.2.2 Cryoablation
5.2.3 Laser
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Speciality Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Diagnostic Centers
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Irrigated Ablation Catheters Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Irrigated Ablation Catheters Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Radiofrequency (RF)
9.6.2 Cryoablation
9.6.3 Laser
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Speciality Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Diagnostic Centers
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Radiofrequency (RF)
10.6.2 Cryoablation
10.6.3 Laser
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Speciality Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Diagnostic Centers
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Radiofrequency (RF)
11.6.2 Cryoablation
11.6.3 Laser
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Speciality Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Diagnostic Centers
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Radiofrequency (RF)
12.6.2 Cryoablation
12.6.3 Laser
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Speciality Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Diagnostic Centers
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Radiofrequency (RF)
13.6.2 Cryoablation
13.6.3 Laser
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Speciality Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Diagnostic Centers
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Irrigated Ablation Catheters Market: Competitive Dashboard
14.2 Global Irrigated Ablation Catheters Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 Osypka AG
14.3.3 Biosense Webster, Inc.
14.3.4 Abbott
14.3.5 Medtronic
14.3.6 Biotronik
14.3.7 MicroPort Scientific
